Clinical trial
Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study
NCT02834260 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 10, 2017
- Completion date
- August 8, 2019
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital hereditary stromal dystrophy of the cornea, fuchs' endothelial dystrophy, keratoconus